Woman Survives Rare Botulism After Eating Fermented Swordfish
Woman Survives Rare Botulism After Eating Fermented Swordfish
Woman Survives Rare Botulism After Eating Fermented Swordfish
A 24-year-old woman from Arizona has survived a rare case of botulism after eating fermented swordfish at a social gathering. Trinity Peterson-Mayes fell seriously ill, suffering paralysis and breathing difficulties that left her hospitalised for weeks. Doctors initially struggled to diagnose her condition before confirming the dangerous infection.
Peterson-Mayes first noticed something was wrong when she struggled to swallow water and nearly choked on coffee. Her symptoms worsened rapidly, leading to paralysis and severe breathing problems. She was rushed to St. Joseph's Medical Center and later transferred to Barrow Neurological Institute, where specialists finally identified botulism as the cause.
The poisoning stemmed from a small piece of fermented swordfish she had sampled in February. The fish, shared among seven health-conscious friends, left her with an unpleasant taste—but she never expected the severe reaction that followed. Two of her friends who also tried the swordfish were briefly hospitalised with the same illness. Botulism is extremely rare, with only around two dozen food-related cases reported annually in the US. Peterson-Mayes, who had already survived childhood cancer twice, faced another life-threatening challenge. Her recovery has been slow, and though she is expected to leave rehab as early as Wednesday, she still tires easily and has not fully regained her strength.
Peterson-Mayes' case highlights the serious risks of improperly prepared fermented foods. While she continues to recover, her experience serves as a warning about the potential dangers of rare but severe foodborne illnesses. Doctors have emphasised the importance of proper food handling to prevent similar incidents.
Geesthacht Hospital shifts to specialist clinic after financial crisis and staff shortages
A once-full-service hospital now fights for survival. How Geesthacht's bold downsizing could redefine local healthcare—or leave patients scrambling.
National health hotline cuts wait times with 24/7 support and AI upgrades
Struggling with long-term illness? This free hotline now answers faster—thanks to AI and smarter systems. See how it's changing patient care.
Novartis bets $3B on unproven breast cancer therapy SNV4818
A $3B gamble on an untested drug could redefine breast cancer care—or backfire. Why Novartis is banking on SNV4818's untapped potential before clinical trials even begin.
How prior authorization delays can harm patients and frustrate doctors
A system meant to cut costs is putting patients at risk. Doctors warn that insurance red tape is delaying care—and even forcing dangerous medication switches.